{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:31:35Z","timestamp":1761741095136,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,31]],"date-time":"2014-08-31T00:00:00Z","timestamp":1409443200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.6061\/clinics\/2014(08)08","type":"journal-article","created":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T11:24:37Z","timestamp":1408101877000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis"],"prefix":"10.1016","volume":"69","author":[{"given":"Paulo D.","family":"Picon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzane Cristina M.","family":"Pribbernow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Prompt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana C.","family":"Schacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica V.H.","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca P.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiane L.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia Mariana B.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando C.","family":"Schacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2007","series-title":"Hematologic aspects of kidney disease","author":"Fishbane","key":"10.6061\/clinics\/2014(08)08_bib1"},{"issue":"11","key":"10.6061\/clinics\/2014(08)08_bib2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V12112465","article-title":"Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%","volume":"12","author":"Collins","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2 Suppl 1","key":"10.6061\/clinics\/2014(08)08_bib3","first-page":"14","article-title":"Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients","volume":"14","author":"Delano","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.6061\/clinics\/2014(08)08_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-111-12-992","article-title":"Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial","volume":"111","author":"Eschbach","year":"1989","journal-title":"Ann Intern Med"},{"year":"2002","series-title":"HRQOL improvements in anemic CKD patients treated with Darbepoetin Alfa (Aranesp TM","author":"Rahman","key":"10.6061\/clinics\/2014(08)08_bib5"},{"article-title":"Minist\u00e9rio da Sa\u00fade - Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade","year":"2002","series-title":"Anemia em pacientes com insufici\u00eancia renal cr\u00f4nica. Protocolos cl\u00ednicos e diretrizes terap\u00eauticas","key":"10.6061\/clinics\/2014(08)08_bib6"},{"issue":"3","key":"10.6061\/clinics\/2014(08)08_bib7","first-page":"5","article-title":"Anemia e uso de eritropoetina nos pacientes em hemodi\u00e1lise no Hospital de Cl\u00ednicas de Porto Alegre","volume":"26","author":"Pribbernow","year":"2006","journal-title":"Rev HCPA"},{"issue":"3","key":"10.6061\/clinics\/2014(08)08_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5935\/0101-2800.20120009","article-title":"[Chronic dialysis in Brazil: report of the Brazilian dialysis census, 2011]","volume":"34","author":"Sesso Rde","year":"2012","journal-title":"J Bras Nefrol"},{"issue":"15","key":"10.6061\/clinics\/2014(08)08_bib9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/jama.297.15.1667","article-title":"Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis","volume":"297","author":"Thamer","year":"2007","journal-title":"JAMA"},{"key":"10.6061\/clinics\/2014(08)08_bib10","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Resolu\u00e7\u00e3o da Diretoria Colegiada. RDC N\u00b0. 154, de 15 de junho de 2004. 2004."},{"issue":"5 Suppl 3","key":"10.6061\/clinics\/2014(08)08_bib11","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"10.6061\/clinics\/2014(08)08_bib12","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.6061\/clinics\/2014(08)08_bib13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinternmed.2009.112","article-title":"The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis","volume":"169","author":"Clement","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.6061\/clinics\/2014(08)08_bib15","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/ki.2008.270","article-title":"Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents","volume":"110","author":"Moist","year":"2008","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.6061\/clinics\/2014(08)08_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0104-42302010000200021","article-title":"Varia\u00e7\u00e3o dos n\u00edveis de hemoglobina de pacientes em hemodi\u00e1lise tratados com eritropoetina: uma experi\u00eancia brasileira","volume":"56","author":"Ammirati","year":"2010","journal-title":"Rev Assoc Med Bras"},{"issue":"4","key":"10.6061\/clinics\/2014(08)08_bib17","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1046\/j.1523-1755.2003.00229.x","article-title":"Hemoglobin variability in epoetin-treated hemodialysis patients","volume":"64","author":"Berns","year":"2003","journal-title":"Kidney Int"},{"issue":"6","key":"10.6061\/clinics\/2014(08)08_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2215\/CJN.01110306","article-title":"Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations","volume":"1","author":"Ebben","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.6061\/clinics\/2014(08)08_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/ajkd.2003.50030","article-title":"Effect of variability in anemia management on hemoglobin outcomes in ESRD","volume":"41","author":"Lacson","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.6061\/clinics\/2014(08)08_bib20","first-page":"7","article-title":"Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters","volume":"23","author":"Costongs","year":"1985","journal-title":"J Clin Chem Clin Biochem"},{"issue":"8","key":"10.6061\/clinics\/2014(08)08_bib21","first-page":"825","article-title":"Within-subject biological variation of hematological quantities and analytical goals","volume":"116","author":"Dot","year":"1992","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.6061\/clinics\/2014(08)08_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/ajcp\/90.3.262","article-title":"Stability of hematologic parameters in healthy subjects. Intraindividual versus interindividual variation","volume":"90","author":"Ross","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.6061\/clinics\/2014(08)08_bib23","first-page":"236A","article-title":"Seasonal variations (SV) in clinical and laboratory parameters in hemodialysis patients","volume":"10","author":"Cheung","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.6061\/clinics\/2014(08)08_bib24","first-page":"549","article-title":"Hemoglobin variability: management inevitable changes in clinical status","volume":"32","author":"Breiterman-White","year":"2005","journal-title":"Nephrol Nurs J"},{"issue":"3","key":"10.6061\/clinics\/2014(08)08_bib25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1523-1755.2005.00532.x","article-title":"Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin","volume":"68","author":"Fishbane","year":"2005","journal-title":"Kidney Int"},{"issue":"8","key":"10.6061\/clinics\/2014(08)08_bib26","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/ndt\/gfm384","article-title":"Evidence and implications of haemoglobin cycling in anaemia management","volume":"22","author":"Fishbane","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"5 Suppl 3","key":"10.6061\/clinics\/2014(08)08_bib27","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"year":"2008","series-title":"Morbidity and mortality: all-cause hospitalization. Annual data report 2008","key":"10.6061\/clinics\/2014(08)08_bib28"},{"key":"10.6061\/clinics\/2014(08)08_bib29","series-title":"Hemodialysis vascular access. The principles and pratices of nephrology","first-page":"766","author":"Schwab","year":"1991"},{"issue":"3","key":"10.6061\/clinics\/2014(08)08_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jvs.2011.07.095","article-title":"Factors affecting the patency of arteriovenous fistulas for dialysis access","volume":"55","author":"Smith","year":"2012","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.6061\/clinics\/2014(08)08_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jvs.2011.04.023","article-title":"Secondary interventions in patients with autologous arteriovenous fistulas strongly improve patency rates","volume":"54","author":"Ayez","year":"2011","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.6061\/clinics\/2014(08)08_bib32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0741-5214(97)70014-4","article-title":"Longitudinal comparison of dialysis access methods: risk factors for failure","volume":"26","author":"Hodges","year":"1997","journal-title":"J Vasc Surg"},{"key":"10.6061\/clinics\/2014(08)08_bib33","series-title":"Vascular access for hemodialyis. Clinical dialysis","first-page":"27","author":"Berkoben","year":"2005"},{"issue":"9","key":"10.6061\/clinics\/2014(08)08_bib34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.6061\/clinics\/2014(08)08_bib35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1046\/j.1523-1755.2000.00289.x","article-title":"Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy","volume":"58","author":"Foley","year":"2000","journal-title":"Kidney Int"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222008808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222008808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-69-08\/cln-69-08-547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:54:02Z","timestamp":1761720842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222008808"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322014000800547&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4129558\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1807593222008808"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2014(08)08","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2014(08)08","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}